February 14, 2020 / 11:37 AM / 5 days ago

BRIEF-Cantargia Advances Development Of CAN04 Through Production Scale Up

Feb 14 (Reuters) - Cantargia AB:

* CANTARGIA ADVANCES DEVELOPMENT OF CAN04 THROUGH SUCCESSFUL PRODUCTION SCALE UP

* REACHED AN IMPORTANT MILESTONE IN DEVELOPMENT OF ITS ANTIBODY PROJECT CAN04, CURRENTLY IN CLINICAL PHASE IIA STUDIES FOR CANCER TREATMENT, WITH FIRST GMP BATCH OF CAN04 IN 2,000-LITRE SCALE

* UPSCALING MEANS THAT CANTARGIA SECURES PRODUCTION METHODOLOGY FOR LATER STAGE CLINICAL TRIALS WITH CAN04 AND TOWARDS COMMERCIAL MANUFACTURING. Source text for Eikon: Further company coverage: (Gdansk Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below